The bottom line, first. Two preclinical experiments make up nearly all of the evidence on CBG as an anti-inflammatory and an antibacterial. In a mouse model of colitis, CBG produced an anti-inflammatory signal (Borrelli 2013). In a lab dish, it showed antibacterial activity against MRSA (Appendino 2008). Neither shows that CBG treats any condition, and nobody has shown it reducing inflammation or fighting infection in people: our registry holds no human study of either. None of it is medical advice.
6 sections · The short answer · CBG and inflammation: one mouse study · CBG, bacteria and MRSA: one lab-dish study · …
The bottom line, first. Brain protection, appetite and glaucoma all turn up in popular searches about CBG, and on all three the internet is well ahead of the science. The neuroprotection and appetite evidence is early and almost entirely preclinical, lab-dish and animal work with marketing layered on top, so those claims belong to the people who make them and sit at Emerging at most, all of them unestablished in people. Glaucoma and eye pressure are a different case. Our registry contains no primary study of CBG and intraocular pressure, either for the claim or against it, and the idea seems to have been borrowed from THC and smoked cannabis, so the record reads: an absence, rather than a finding against. We do not recommend CBG for your eyes.
6 sections · CBG and neuroprotection: what is known · CBG and appetite · CBG, glaucoma and eye pressure: correcting a common myth · …